Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

24,258 signal articles · 46 in last 24h · 115,243 total before filter · latest 1h ago
46last 24h
1804last 7d
299● bullish (7d)
171● bearish (7d)
205publishers
AllMacro322Earnings851M&A105Regulatory25Product16Analyst25
✕ clear all filtersticker: CVSSentiment:bullishneutralbearishshow all (incl. clickbait)
Amazon looks to redefine a need for speed with 30-minute deliveries
Associated Press95d agoneutral
Amazon looks to redefine a need for speed with 30-minute deliveries

More than 20 years after it redefined fast shipping, Amazon is preparing to raise the bar on consumer expectations again by offering to fulfill customers' most urgent product needs in a half-hour or less for an extra fee. The company, which revolutionized online shopping in 2005 with two-day deliveries for Prime members, is rapidly opening small order-processing hubs in dozens of U.S. and foreign cities to cater to shoppers who can't or don't want to wait for cough medicine to relieve flu symptoms or tomatoes for tonight's dinner salad. The ultrafast service, called Amazon Now, first launched in India last June.

A Look At CVS Health (CVS) Valuation After Earnings Beat And Raised 2026 Guidance
Simply Wall St.96d agobullish
A Look At CVS Health (CVS) Valuation After Earnings Beat And Raised 2026 Guidance

CVS Health (CVS) is back in focus after first quarter 2026 results and raised full year guidance, with management highlighting broad based strength across Aetna, Health Services, and Pharmacy & Consumer Wellness. See our latest analysis for CVS Health. After the earnings beat and guidance raise, the share price has climbed to US$90.55, with a 1 month share price return of 14.14% and a 1 year total shareholder return of 44.83%. This suggests momentum has picked up recently compared with longer...

Morgan Stanley drops one big takeaway in CVS stock earnings beat
TheStreet97d agobearish
Morgan Stanley drops one big takeaway in CVS stock earnings beat

Healthcare stocks have had a rough stretch. Rising medical costs, Medicaid pressure, and persistent skepticism about managed care margins have kept investors on edge all year. Walking into a CVS Health earnings report in that environment felt like bracing for bad news. The bad news, however, didn't ...

CVS Health Q1 Earnings Call Highlights
MarketBeat97d agoneutral
CVS Health Q1 Earnings Call Highlights

CVS Health (NYSE:CVS) raised its full-year 2026 adjusted earnings outlook after reporting stronger first-quarter results, with management citing improved performance at Aetna, continued execution at Caremark and resilient pharmacy operations. On the company’s first-quarter earnings call, David Joyn

Knorr-Bremse Q1 Earnings Call Highlights
MarketBeat100d agoneutral
Knorr-Bremse Q1 Earnings Call Highlights

Knorr-Bremse (ETR:KBX) opened 2026 with what CEO Marc Llistosella described as the company’s “best first quarter in the past 5 years,” citing margin recovery in the commercial vehicle business and a record order backlog in its rail division. Management also reiterated its full-year guidance, while n

More Record Highs — Heard on the Street Wednesday Recap
The Wall Street Journal100d agobullish
More Record Highs — Heard on the Street Wednesday Recap

Oil prices fell and stocks rose on rising optimism about an end to Middle East hostilities. Iran and the U.S. are working with mediators on a one-page framework to restart negotiations aimed at ending the conflict and opening the Strait of Hormuz, with talks potentially beginning next week in Islamabad. Semiconductor stocks extended their rally.

CVS Health tops Q1 estimates, raises full-year guidance
Proactive101d agobullish
CVS Health tops Q1 estimates, raises full-year guidance

CVS Health Corp (NYSE:CVS) shares rose about 6% on Wednesday morning after the retail pharmacy chain reported first quarter financial results that topped Wall Street expectations on both earnings and revenue. The company posted adjusted earnings per share (EPS) of $2.57, compared with analyst...